Lumiracoxib is an Orally Active COX-2 Inhibitor for Inflammation Research
Prostaglandins are pivotal in regulating inflammatory processes, acting as autocrine factors that control platelet aggregation, vascular tone, oedema, exocrine gland secretions, and neuronal responses to pain. Prostaglandin production hinges on…